Xenikos
0 followers
‌
Xenikos is developing a combination of two toxin-loaded anti-T-cell antibodies.
Industries
+1
Employees
Links
Org chart
André de Lege
Controller & Accountant
Maria Marza Perez
CMC Project Manager
Jürgen van de Lagemaat
Director, Process Development & Commercialization
